在老年大脑中状上皮质的形态和分子特征
1Department of Pathology and Host Defense, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Takamatsu 761-0793, Kagawa, Japan.
International journal of molecular sciences
|March 14, 2026
概括
冠状动脉 (CP) 表皮发生退化,包括细胞损失,过度缩和线粒体变化,导致CP扩大. 这一过程有助于血液-脑脊液屏障功能障碍在衰老和神经系统疾病.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 医疗成像医学成像
背景情况:
- 胸膜 (CP) 越来越多地被认为具有超出脑脊液产生的作用,包括免疫监测和代谢平衡.
- 在衰老和各种神经系统疾病中观察到CP扩大,但细胞机制尚不清楚.
研究的目的:
- 提出一个顺序退行模型,用于胆脉上皮质.
- 整合形态,分子和成像数据来解释CP扩大.
主要方法:
- 形态,分子和神经成像证据的综合.
- 对CP上皮细胞的退行模型的开发.
- 涉及SPINT1和E-cadherin的分子通路的分析.
主要成果:
- 一个四个阶段的退行模型:细胞损失,增大,线粒体重塑 (细胞变化) 和屏障功能障碍.
- 表皮不稳定与SPINT1和E-cadherin的改变有关.
- 在高缩细胞中增加线粒体负荷 (Tom20表达),导致氧化应激.
结论:
- 脑膜大是表皮压力和功能障碍的可见迹象.
- 拟议的模型为理解脑衰老和神经退行过程中的CP变化提供了结构分子基础.
- 这一框架有助于解释各种神经疾病中的CP变化.
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


